-+ 0.00%
-+ 0.00%
-+ 0.00%

ASSEMBLY BIOSCIENCES EXERCISES U.S. PROFIT-SHARE OPTION WITH GILEAD FOR HSV HELICASE-PRIMASE INHIBITOR PROGRAM

Reuters·09/08/2026 20:00:00

Please log in to view news